Results 61 to 70 of about 59,185 (303)

Herpes Zoster Vaccination

The Korean Journal of Pain, 2013
Varicella (chickenpox) is a highly contagious airborne disease caused by primary infection with the varicella zoster virus (VZV). Following the resolution of chickenpox, the virus can remain dormant in the dorsal sensory and cranial ganglion for decades.
openaire   +2 more sources

Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting

Annals of Internal Medicine
BACKGROUND A 2-dose series of recombinant zoster vaccine (RZV) was 97% effective against herpes zoster (HZ) in a pivotal clinical trial. OBJECTIVE To evaluate real-world effectiveness of RZV against HZ. DESIGN Prospective cohort study. SETTING Four
O. Zerbo, J. Bartlett, B. Fireman, N. Lewis, Kristin Goddard, K. Dooling, J. Duffy, J. Glanz, Allison L. Naleway, James G Donahue, Nicola P. Klein   +10 more
semanticscholar   +1 more source

Systematic evaluation of the pharmacoeconomics research on herpes zoster vaccine administration: a systematic review

Zhongguo gonggong weisheng
ObjectiveTo systematically evaluate the pharmacoeconomic research on herpes zoster (HZ) vaccine administration, providing reference for related research and prevention of HZ.
Xinping LIU, Ziyi YANG, Xinyu LI, Yulan CHANG, Lei TIAN   +4 more
doaj   +1 more source

Risk of Herpes Zoster in Individuals on Biologics, DMARDS and/or Corticosteroids for Autoimmune Diseases:A Systematic Review and Meta-Analysis [PDF]

, 2016
Background: Studies examining the risk of herpes zoster (HZ) associated with immunosuppressants, such as biologics, non-biological disease modifying agents (nbDMARDs) or corticosteroids, have generated conflicting results.
Alarcón-Segovia, Bachelez, Bejarano, Bongartz, Braun, Brenner, Bresnihan, Cardiel, Che, Chen, Choy, Cohen, Cutolo, Dechartres, Dixon, Dixon, Dreiher, Egger, Emery, Emery, Fleischmann, Fleischmann, Furie, Furst, Galloway, Genovese, Genovese, Gupta, Gupta, Harpaz, Hayward, Higgins, Higgins, Hoes, Kameda, Kawai, Keystone, Kost, Kourbeti, Kremer, Kremer, Kremer, Kremer, Lal, Leonardi, Long, McDonald, Merrill, Moher, Moreland, Moutsopoulos, Nakajima, Nishimoto, Osterman, Oxman, Oxman, Papp, Pappas, Peto, Rutgeerts, Sampathkumar, Sandborn, Sandborn, Schiff, Schreiber, Segan, Shah, Singh, Smitten, Smolen, Smolen, Spittal, Strangfeld, Stroup, Sweeting, Takeuchi, Tanaka, Tanaka, van der Heijde, van Vollenhoven, Veetil, Weiner, Wells, Winthrop, Winthrop, Winthrop, Wolfe, Yamamoto, Yawn, Yawn, Youssef, Yun, Zhang, Zisman, Zorzela   +94 more
core   +1 more source

Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study

The Lancet Public Health, 2018
Background: In 2013, a herpes zoster vaccination programme was introduced in England for adults aged 70 years with a phased catch-up programme for those aged 71–79 years.
Gayatri Amirthalingam, MFPH, Nick Andrews, PhD, Philip Keel, MSc, David Mullett, MA, Ana Correa, MSc, Simon de Lusignan, MD, Mary Ramsay, FFPH   +6 more
doaj   +1 more source

Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study. [PDF]

, 2016
OBJECTIVE: To investigate risk factors for postherpetic neuralgia, the neuropathic pain that commonly follows herpes zoster. METHODS: Using primary care data from the Clinical Practice Research Datalink, we fitted multivariable logistic regression models
Bhaskaran, Krishnan, Clayton, Tim, Forbes, Harriet J, Langan, Sinéad M, Mansfield, Kathryn, Minassian, Caroline, Smeeth, Liam, Thomas, Sara L   +7 more
core   +1 more source

Herpes Zoster Vaccine

Uirusu, 2018
Herpes zoster, or shingles, results from the reactivation of latent varicella- zoster virus (VZV) in the dorsal-root or cranial-nerve ganglia, usually decades after primary infection. Herpes zoster is characterized by a vesicular rash with a unilateral and dermatomal distribution and is almost always accompanied by pain.
openaire   +3 more sources

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine

Journal of Infectious Diseases, 2020
Background Efficacy of the live-attenuated herpes zoster (HZ) vaccine (ZVL) wanes substantially over time. We evaluated immunogenicity and safety of the adjuvanted recombinant zoster vaccine (RZV) in previous ZVL recipients. Methods Adults aged ≥65 years
Alemnew F Dagnew, N. Klein, C. Hervé, George Kalema, E. Di Paolo, James T Peterson, B. Salaun, A. Schuind   +7 more
semanticscholar   +1 more source

Herpes Zoster in an Immunocompetent Child without a History of Varicella

Pediatric Reports, 2021
Herpes zoster is a relatively rare infectious disease in the pediatric population, as compared with adults, which is due to the reactivation of latent Varicella−Zoster virus.
Bing-Shiau Shang, Cheng-Jui Jamie Hung, Ko-Huang Lue   +2 more
doaj   +1 more source

A systematic review and meta-analysis of risk factors for postherpetic neuralgia. [PDF]

, 2015
Patients with herpes zoster can develop persistent pain after rash healing, a complication known as postherpetic neuralgia. By preventing zoster through vaccination, the risk of this common complication is reduced.
Bhaskaran, Krishnan, Clayton, Tim, Farmer, Ruth, Forbes, Harriet J, Langan, Sinéad M, Smeeth, Liam, Thomas, Sara L   +6 more
core   +1 more source